Gosebruch Henry O - 16 May 2022 Form 4/A - Amendment Insider Report for AbbVie Inc. (ABBV)

Role
EVP, Chief Strategy Officer
Signature
Steven L. Scrogham, attorney-in-fact for Henry O. Gosebruch
Issuer symbol
ABBV
Transactions as of
16 May 2022
Net transactions value
-$13,013,800
Form type
4/A - Amendment
Filing time
20 May 2022, 17:03:56 UTC
Date Of Original Report
18 May 2022
Previous filing
20 May 2022
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $4,606,046 +83,960 +202% $54.86 125,583 16 May 2022 Direct
transaction ABBV Common Stock, $0.01 par value Sale $13,013,800 -83,960 -67% $155.00 41,623 16 May 2022 Direct
holding ABBV Common Stock, $0.01 par value 53,500 16 May 2022 In trust F1
holding ABBV Common Stock, $0.01 par value 3,638 16 May 2022 Profit sharing trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to Buy) Options Exercise $4,606,046 -83,960 -100% $54.86 0 16 May 2022 Common Stock 83,960 $54.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2 Balance in AbbVie Savings program as of May 18, 2022.
F3 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

Direct and indirect ownership totals updated to reflect the May 20, 2022 amendment to the reporting person's Form 4 filed on March 2, 2022.